Interestingly, the ability of CCN3 to promote the formation of osteolytic bone metastases may reflect the fact that breast cancer cells colonizing the bone would contribute to significantly elevated levels of CCN3, which would tip the balance towards osteoclastogenesis (Fig. 3). This evidence concerns the gene CCN3 and breast cancer.